P53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-γ

Experimental Cell Research

Volumn 262, Issue 2, 2001, Pages 154-169

  Meng, Raymond D ^a   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Betulinic acid; Dexamethasone; Interferon ; KILLER DR5; P53; STAT1; TNF ; TRAIL receptor; lapachone

Indexed keywords

BETA LAPACHONE; BETULIC ACID; DACTINOMYCIN; DEXAMETHASONE; DNA TOPOISOMERASE INHIBITOR; GAMMA INTERFERON; GLUCOCORTICOID; MEMBRANE RECEPTOR; MESSENGER RNA; P53 REGULATED PROAPOPTOTIC TRAIL DEATH RECEPTOR 5; PREDNISOLONE; PROTEIN P53; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; GLIOBLASTOMA; HUMAN; HUMAN CELL; MELANOMA; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

EID: 0035862189     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5073     Document Type: Article

References (82)

1. The p53 pathway and cancer therapy
2. p53, the cellular gatekeeper for growth and division
3. WAF1, a potential mediator of p53 tumor suppression
4. BCL-2 family: Regulators of cell death
5. A model for p53-induced apoptosis
6. Apoptosis by death factor
7. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
8. p53-dependent DNA damage-induced apoptosis requires Fas/APO-l-independent activation of CPP32β
9. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
10. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
11. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
12. Characterization of two receptors for TRAIL
13. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB
14. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
15. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
16. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
17. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signals from TRAIL
18. Death receptors: Signaling and modulation
19. TRAIL: A molecule with multiple receptors and control mechanisms
20. Apoptosis signaling by death receptors
21. The receptor for the cytotoxic ligand TRAIL
22. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
23. A novel receptor for Apo2L/TRAIL contains a truncated death domain
24. Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): A new receptor protecting lymphocytes from the death ligand TRAIL
25. Genomic organization and mutation analyses of the DR5/TRAIL receptor 2 gene in colorectal carcinomas
26. Rare loss-of-function mutation of a death receptor gene in head and neck cancer
27. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor α
28. WAF1/CIP1 expression by p53-independent pathways
29. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases
30. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2
31. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression
32. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of Adriamycin
33. p53 and chemosensitivity
34. In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug
35. β-Lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: A p53-independent response
36. Induction of apoptosis by β-lapachone in human prostate cancer cells
37. Topoisomerase I inhibitors for human malignant glioma: Differential modulation of p53, p21, bax, and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and β-lapachone
38. Induction of apoptosis in MCF-7:WS8 breast cancer cells by β-lapachone
39. Beta-lapachone induced cell death in human hepatoma (HepA2) cells
40. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
41. Betulinic acid induces apoptosis in human neuroblastoma cell lines
42. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors
43. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
44. Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells
45. Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-κB-dependent transcription
46. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in culture keratinocytes
47. Fas expression and function in normal and malignant breast cancer cell lines
48. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression
49. How cells respond to interferons
50. Inhibition of radiation-induced neoplastic transformation by β-lapachone
51. Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones
52. Involvement of hydrogen peroxide in topoisomerase inhibitor β-lapachone-induced apoptosis and differentiation in human leukemia cells
53. 2-terminal kinase and subsequent CPP32/YAMA during topoisomerase inhibitor β-lapachone-induced apoptosis through an oxidation-dependent pathway
54. 2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways
55. JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL, and TNF-α
56. Lack of correlation in JNK activation and p53-dependent Fas expression induced by apoptotic stimuli
57. Steroid hormone receptors: Many actors in search of a plot
58. Mechanism of gene expression by the glucocorticoid receptor: Role of protein - Protein interactions
59. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor
60. Dexamethasone-induced thymocyte apoptosis: Apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases
61. T cells from bax-α transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53
62. p53 is required for radiation-induced apoptosis in mouse thymocytes
63. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells
64. waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells
65. Role of calcium in glucocorticosteroid-induced apoptosis of thymocytes and lymphoma cells: Resurrection of old theories by new findings
66. Regulation of ceramide production and apoptosis
67. Potent and specific inhibitors of protein kinase C of microbial origin
68. Investigation of glucocorticoid-induced apoptotic pathway: Processing of caspase-6 but not caspase-3
69. Apoptosis induction by the glucocorticoid hormone dexamethasone and the calcium-ATPase inhibitor thapsigargin involves bcl-2 regulated caspase activation
70. Cell cycle regulation and apoptosis
71. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand
72. Coregulation of the APO-1 antigen with intracellular adhesion molecule-1 (CD54) in tonsilar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas
73. MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells
74. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression
75. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions
76. Drug-induced apoptosis is associated with enhanced Fas (APO-1/CD95) ligand expression but occurs independently of Fas (APO-1/CD95) signaling in human T-acute lymphatic leukemia cells
77. WAF1/CIP1
78. STAT-1 independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs
79. An IRF-l-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
80. Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3
81. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
82. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo